NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2026
Voltar para busca
Dado oficial do USPTO
ATON
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
30/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
08/12/2023
Data de registro
08/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/04/2025
Última transação
30/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
HUSSAIN, TASNEEM
Unidade examinadora
M90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
HYBRIGENICS SA
Representantes
Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical productschemical additiveschemical active ingredientschemical solventschemical reagentschemical preservativeschemical antioxidantsethylene oxideethylene glycolchlorine for use in the manufacture of pharmaceuticals; active chemical ingredients intended for the manufacture of medicines for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; biological preparations other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; cultures of microorganisms other than for medical or veterinary use; stem cells other than for medical or veterinary use; protein being raw material for scientific and medical research; vitamins for manufacturing pharmaceutical products; chemical reagents other than for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistryclinical chemistry and microbiology other than for medical use; chemical reagents for developing monoclonal antibodies other than for medical or veterinary use; monoclonal antibodies for diagnostic usefor scientific purposes other than medical; monoclonal antibodies for industrial scientific research use; chemical substances for analyses in laboratoriesother than for medical or veterinary purposes intended for the biotechnology industry
Classe 5
Pharmaceutical products for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; chemical pharmaceutical preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; veterinary products for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; sanitary sterilizing preparations; chemical preparations for pharmaceutical use for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; chemical preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for medical use; chemical preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for veterinary use; pharmaceutical products for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes; biologicalbiochemical and biotechnological preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for medical use; medicines for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for human useremedies for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for human use; medicines for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for veterinary useremedies for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for veterinary use; stem cells for medical use; stem cells for veterinary use; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of micro-organisms for medical use; skin grafts being living tissues; surgical implants made of living tissue; antibodies; diagnostic preparations for medical use; diagnostic preparations for veterinary use; in-vitro diagnostic preparations for medical use; biotechnological preparations for treating viral and infectious diseasescancerneurodegenerative diseasesobesity and diabetes for medical use; chemical reagents for medical and veterinary use; diagnostic biomarking reagents for medical use; antibiotics
Classe 42
Scientific and industrial research and development of vaccines and medicines; engineering; product research and development in industrial processes; product research and development concerning the automation of industrial processes; surveyingengineering work; biological research; medical research; chemical research; scientific laboratory services; laboratory services for medical research; scientific laboratory services for studiesresearch and analysis in the field of chemistry and biology; scientific and technological research relating to patent mapping; research and development in the field of antibodies; research and development in the field of microorganisms and cells; research and development in the field of biochemistry and biotechnology; information about scientific research in the field of biochemistry and biotechnology; technological consultancy services in the technology field of biotechnology and medical technologies; scientific research in the nature of conducting clinical trials for others; testing of materials; scientific and industrial researchfine tuning industrial processestroubleshooting of industrial process control computer software problemsdata automation using proprietary software to evaluateanalyze and collect service dataprofessional scientific consultancymaterial testingscientific laboratory servicescomputer programmingall these services being dedicated to biologybioinformaticsbiochemistrybiotechnologypharmacyproteomicsgenomicscosmetics and agronomy; industrial and scientific research services in the field of molecular biology and more specifically genomicsproteomicsprotein screening and protein interaction research; scientific research and analysis in the field of genetics and genetic engineering and in the field of chemical reagents; research and development of new products for third parties; development and maintenance of computer platforms in the field of the pharmaceutical industry and biotechnology; computer platform as a service PaaS featuring software for scientific analysis and research in the field of the pharmaceutical industry and biotechnology; software engineering services for data processing in the field of the pharmaceutical industry and biotechnology; computer programming services for data processing in the field of the pharmaceutical industry and biotechnology; developing and hosting databases in the field of the pharmaceutical industry and biotechnology; scientific data analysis in the field of the pharmaceutical industry and biotechnology; electronic storage of data in the field of the pharmaceutical industry and biotechnology; engineering services for developing computer data banks in the field of the pharmaceutical industry and biotechnology; developing and providing online non-downloadable computer software platforms for scientific analysis and research and antibody data bankdata warehousing
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
14/05/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
15/11/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
15/11/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/10/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
29/10/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
25/10/2025
FIMP
FINAL DISPOSITION PROCESSED
24/10/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/02/2025
PUBO
PUBLISHED FOR OPPOSITION
18/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/01/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/01/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/01/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/01/2025
RFNT
REFUSAL PROCESSED BY IB
25/08/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/08/2024
RFRR
REFUSAL PROCESSED BY MPU
02/08/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/07/2024
CNRT
NON-FINAL ACTION WRITTEN
10/07/2024
DOCK
ASSIGNED TO EXAMINER
09/07/2024
MAFR
APPLICATION FILING RECEIPT MAILED
01/06/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/05/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ATON ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.